RAGE Gene Polymorphisms Are Associated with Circulating Levels of Endogenous Secretory RAGE but Not with Coronary Artery Disease in Chinese Patients with Type 2 Diabetes Mellitus

Archives of Medical Research

Volumn 40, Issue 5, 2009, Pages 393-398

  Peng, Wen Hui ^a   Lu, Lin ^a   Wang, Ling Jie ^a   Yan, Xiao Xiang ^a   Chen, Qiu Jing ^a   Zhang, Qi ^a   Zhang, Rui Yan ^a   Shen, Wei Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Coronary artery disease; esRAGE; Polymorphism; Receptor for advanced glycation end products; Type 2 diabetes mellitus

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR;

AGED; ALLELES; C-REACTIVE PROTEIN; CHINA; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349101583     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2009.06.008     Document Type: Article

References (27)

1. Stamler J., Vaccaro O., Neaton J.D., et al. Diabetes, other risk factors, and 12 yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16 (1993) 434-444
2. Gu K., Cowie C.C., and Harris M.I. Diabetes and decline in heart disease mortality in US adults. JAMA 281 (1999) 1291-1297
3. Goldin A., Beckman J.A., Schmidt A.M., et al. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114 (2006) 597-605
4. Basta G. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications. Atherosclerosis 196 (2008) 9-21
5. Bucciarelli L.G., Wendt T., Qu W., et al. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation 106 (2002) 2827-2835
6. Sakurai S., Yamamoto Y., Tamei H., et al. Development of an ELISA for esRAGE and its application to type 1 diabetic patients. Diabetes Res Clin Pract 73 (2006) 158-165
7. Koyama H., Shoji T., Yokoyama H., et al. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 25 (2005) 2587-2593
8. Koyama H., Shoji T., Fukumoto S., et al. Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 27 (2007) 147-153
9. Sugaya K., Fukagawa T., Matsumoto K., et al. Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3. Genomics 23 (1994) 408-419
10. Pettersson-Fernholm K., Forsblom C., Hudson B.I., et al. The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes 52 (2003) 891-894
11. Falcone C., Campo I., Emanuele E., et al. -374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis. Clin Chim Acta 354 (2005) 111-116
12. Falcone C., Campo I., Emanuele E., et al. Relationship between the -374T/A RAGE gene polymorphism and angiographic coronary artery disease. Int J Mol Med 14 (2004) 1061-1064
13. Kumaramanickavel G., Ramprasad V.L., Sripriya S., et al. Association of Gly82Ser polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patients. J Diabetes Complications 16 (2002) 391-394
14. Kankova K., Zahejsky J., Marova I., et al. Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM. J Diabetes Complications 15 (2001) 185-192
15. Jang Y., Kim J.Y., Kang S.M., et al. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans. Metabolism 56 (2007) 199-205
16. Kalousova M., Jachymova M., Mestek O., et al. Receptor for advanced glycation end products-soluble form and gene polymorphisms in chronic haemodialysis patients. Nephrol Dial Transplant 22 (2007) 2020-2026
17. Tesarova P., Kalousova M., Jachymova M., et al. Receptor for advanced glycation end products (RAGE)-soluble form (sRAGE) and gene polymorphisms in patients with breast cancer. Cancer Invest 25 (2007) 720-725
18. Katakami N., Matsuhisa M., Kaneto H., et al. Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications. Diabetes Care 28 (2005) 2716-2721
19. Nakamura K., Yamagishi S., Adachi H., et al. Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease. Diabetes Metab Res Rev 23 (2007) 368-371
20. Lu L., Pu L.J., Xu X.W., et al. Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus. Clin Biochem 40 (2007) 810-816
21. Hudson B.I., Stickland M.H., Futers T.S., et al. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 50 (2001) 1505-1511
22. Picheth G., Costantini C.O., Pedrosa F.O., et al. The -374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients. Clin Chem Lab Med 45 (2007) 1268-1272
23. Falcone C., Geroldi D., Buzzi M.P., et al. The -374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease. Arch Med Res 39 (2008) 320-325
24. Hofmann M.A., Drury S., Hudson B.I., et al. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun 3 (2002) 123-135
25. Yonekura H., Yamamoto Y., Sakurai S., et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 370 (2003) 1097-1109
26. Koyama H., Yamamoto H., and Nishizawa Y. RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases. Mol Med 13 (2007) 625-635
27. Wackers F.J., Young L.H., Inzucchi S.E., et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27 (2004) 1954-1961